Tokyo University AI startup Simulacra raises pre-seed round, led by ANRI
What's the deal? SimulacraDealroom has a profile for this one. Try Dealroom →, a Tokyo-based AI startup spun out of the University of Tokyo, has raised an undisclosed pre-seed round led by ANRIDealroom has a profile for this one. Try Dealroom →. The company builds "digital twin" foundation models that use AI to replicate how people think and behave.
Why now? The round ran through ANRI's new pre-seed program, launched alongside its sixth fund, which ANRI calls one of Japan's largest for an independent seed firm. The deal was announced in November 2026.
What's the endgame? Simulacra aims to combine thousands of individual digital twins into a model of whole organisations and societies. The goal: let companies and governments test policies, products, and rules in simulation before rolling them out, shifting decisions away from gut instinct.
Founded in September 2025 from the University of Tokyo's Izumi Lab, the company sells an interview AI that draws out people's values through conversation, plus consumer, economic, and urban digital twins.
Who's backing it? ANRI principal Taro Maruyama said the firm was drawn to Simulacra's "grand vision" and "unwavering will," comparing the technology to a kind of future prediction. Funds will go toward model research, hiring researchers and engineers, and expanding joint projects with companies and municipalities.
Why it matters. Simulacra has moved past a research-only pitch in its first year. In April 2026, it open-sourced its LLM-agent simulation platform, EconSimulacra, under an MIT licence, and had a paper accepted at ACL 2026. It also joined a JST-backed social-science AI project with the University of Tokyo and RIKENDealroom has a profile for this one. Try Dealroom →, part of a ¥32 billion national program.
What could go wrong? The core bet is unproven: whether simulations of people and societies can reliably predict real-world responses. The announcement gives no commercial traction figures, so adoption by businesses or public bodies remains to be shown.
The signal: ANRI's backing marks a bet on research-to-product momentum at a very early, high-uncertainty stage. For now, Simulacra's story is about a promising lab-born technology reaching for real-world use — not proven demand.
Read more: prtimes.jp
Image credit: Dick Thomas Johnson
